| Participants (n = 100) |
Gender female, n (%) | 50 (50%) |
Clinical experience as physician (y), mean (SD) | 12.48 (±8.23) |
Number of ulcerative colitis patients in the center, n (%)* none 1 to 10 10 to 50 50 to 100 >100 |
1 (1.0%) 25 (26.0%) 52 (54.2%) 12 (12.5%) 6 (6.3%) |
Number of Crohn’s disease patients in the center, n (%)** none 1 to 10 10 to 50 50 to 100 >100 |
1 (1.0%) 35 (35.4%) 45 (45.5%) 12 (12.0%) 6 (6.1%) |
Number of ulcerative colitis patients receiving biological therapy, n (%)*** none 1 to 10 10 to 50 50 to 100 >100 |
18 (19.4%) 52 (55.9%) 19 (20.4% 3 (3.2%) 1 (1.1%) |
Number of Crohn’s disease patients receiving biological therapy, n (%)** none 1 to 10 10 to 50 50 to 100 >100 |
5 (5.1%) 51 (51.5%) 37 (37.4%) 3 (3.0%) 3 (3.0%) |